Real Estate -
REIT - Mortgage - NYSE - US
$ 18.47
-2.99 %
$ 138 M
Market Cap
16.06
P/E
1. INTRINSIC VALUE
Balance Sheet
ACRES Commercial Realty Corp.
| Current Assets | 71.4 M |
| Cash & Short-Term Investments | 56.7 M |
| Receivables | 16.9 M |
| Other Current Assets | -2.29 M |
| Non-Current Assets | 26.9 M |
| Long-Term Investments | 0 |
| PP&E | 19.9 M |
| Other Non-Current Assets | 6.99 M |
| Current Liabilities | 11.1 M |
| Accounts Payable | 6.96 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 4.17 M |
| Non-Current Liabilities | 1.41 B |
| Long-Term Debt | 1.41 B |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
ACRES Commercial Realty Corp.
| Revenue | 83.5 M |
| Cost Of Revenue | 46.9 M |
| Gross Profit | 36.6 M |
| Operating Expenses | 25 M |
| Operating Income | 11.6 M |
| Other Expenses | -17.1 M |
| Net Income | 28.7 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ACRES Commercial Realty Corp.
| Net Income | 28.7 M |
| Depreciation & Amortization | 9.69 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 2.96 M |
| Change in Working Capital | 0 |
| Others | -25.5 M |
| Free Cash Flow | 19.4 M |
Wall Street Analysts Price Targets
ACRES Commercial Realty Corp.
Wall Street analysts predict an average 1-year price target for ACR of $16.5 , with forecasts ranging from
a
low of
$14 to a high of $18.5 .
ACR Lowest Price Target
Wall Street Target
14 USD
-24.20%
ACR Average Price Target
Wall Street Target
16.5 USD
-10.67%
ACR Highest Price Target
Wall Street Target
18.5 USD
0.16%
4. DIVIDEND
ANALYSIS
4.50%
DIVIDEND YIELD
0.825 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
ACRES Commercial Realty Corp.
Sold
0-3 MONTHS
1.93 M USD 1
3-6 MONTHS
3.82 M USD 1
6-9 MONTHS
4.72 M USD 1
9-12 MONTHS
982 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platform Capabilities and Clinical ACR-368 and ACR-2316 Program Updates
Event to be held via webcast on March 25, 2025 at 4:00 p.m. ET To highlight differentiated drug discovery capabilities with its Generative Phosphoproteomics AP3 platform and program updates from the Phase 2b study of ACR-368 and Phase 1 study of ACR-2316 WATERTOWN, Mass.
globenewswire.com
- 3 weeks ago
ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock
UNIONDALE, N.Y. , March 18, 2025 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that its Board of Directors declared cash dividends on its Preferred Stock.
prnewswire.com
- 3 weeks ago
ACRES Commercial Realty Corp. Announces Redemption of CRE Securitizations and Closing of a $940 Million Managed Facility Backed by Commercial Mortgage Loans
UNIONDALE, N.Y. , March 17, 2025 /PRNewswire/ -- ACRES Commercial Realty (NYSE: ACR) (the "Company") announced that it repurchased the assets in ACRES Commercial Realty 2021-FL1 and ACRES Commercial Realty 2021-FL2 in their entirety and brought the existing JP Morgan warehouse facility balance to zero.
prnewswire.com
- 3 weeks ago
ACRES Commercial Realty: Are The Commons Still A Buy?
ACRES Commercial Realty Corp. is up substantially over the last 1-year as the mREIT moves to close its discount to book value. ACR's book value grew by 95 cents sequentially to $28.87 per share, with the commons currently trading hands at a 27% discount to book value. The floating rate Series C preferreds are a play for income, currently paying out a 10.4% yield on cost but trading 22 cents above their liquidation value per share.
seekingalpha.com
- 1 month ago
ACRES Commercial Realty Corp. (ACR) Q4 2024 Earnings Call Transcript
Start Time: 10:00 January 1, 0000 10:18 AM ET ACRES Commercial Realty Corp. (NYSE:ACR ) Q4 2024 Earnings Conference Call March 06, 2025, 10:00 AM ET Company Participants Mark Fogel - President and CEO Eldron Blackwell - CFO Andrew Fentress - Chairman Kyle Brengel - VP, Operations Conference Call Participants Matthew Erdner - Jones Trading Chris Muller - Citizens Bank Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2024 ACRES Commercial Realty Corp. Earnings Conference Call. Currently, all participants are in a listen-only mode.
seekingalpha.com
- 1 month ago
ACRES Commercial (ACR) Q4 Earnings Surpass Estimates
ACRES Commercial (ACR) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.55 per share a year ago.
zacks.com
- 1 month ago
ACRES COMMERCIAL REALTY CORP. REPORTS RESULTS FOR FOURTH QUARTER 2024 AND YEAR ENDED DECEMBER 31, 2024
UNIONDALE, N.Y. , March 5, 2025 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) ("ACR" or the "Company"), a real estate investment trust that is primarily focused on originating, holding and managing commercial real estate mortgage loans and equity investments in commercial real estate property through direct ownership and joint ventures, today reported results for the quarter and year ended December 31, 2024.
prnewswire.com
- 1 month ago
ACRES Commercial Realty Corp. to Report Results for Fourth Quarter 2024
UNIONDALE, N.Y. , Feb. 19, 2025 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that it will release its results for the fourth quarter 2024, on Wednesday, March 5, 2025, after the market closes.
prnewswire.com
- 1 month ago
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs. placebo Achieved statistical significance on key secondary endpoints at Week 12 on ACR20, ACR50 and CDAI LDA Demonstrated highest ever reported responses on key secondary endpoints at Week 14 on ACR20, ACR50, ACR70 and CDAI LDA 69% of rosnilimab-treated patients achieved CDAI LDA at Week 14 and appear to show sustained CDAI LDA and ACR50 responses and potentially deepening ACR70 responses out to Week 28 Robust pharmacological activity observed in reduction of PD-1high T cells, increase in total Tregs and reduction of CRP across all doses Rosnilimab was safe and well tolerated with similar adverse event rates vs.
globenewswire.com
- 1 month ago
ACRES Commercial Realty Corp. Reauthorizes an Additional $5 Million Share Repurchase Program
UNIONDALE, N.Y. , Dec. 19, 2024 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that its board of directors (the "Board") authorized and approved the continued use of its existing share repurchase program to repurchase an additional $5 million of the outstanding shares of both its common and preferred stock.
prnewswire.com
- 3 months ago
ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock
UNIONDALE, N.Y. , Dec. 19, 2024 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that its Board of Directors declared cash dividends on its Preferred Stock.
prnewswire.com
- 3 months ago
The Only 3 REITs You Need to Own In Your Lifetime
Investing in real estate investment trusts (REITs) is an excellent option for long-term investors looking to create meaningful passive income streams in retirement.
247wallst.com
- 3 months ago
8. Profile
Summary
ACRES Commercial Realty Corp. ACR
COUNTRY
US
INDUSTRY
REIT - Mortgage
MARKET CAP
$ 138 M
Dividend Yield
4.50%
Description
ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and other commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including floating and fixed rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments, commercial mortgage-backed securities, and commercial real estate equity and preferred equity investments. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Exantas Capital Corp. and changed its name to ACRES Commercial Realty Corp. in February 2021. ACRES Commercial Realty Corp. was incorporated in 2005 and is based in Uniondale, New York.
Contact
390 RXR Plaza, Uniondale, NY, 11556
https://www.acresreit.com
IPO
Date
Feb. 7, 2006
Employees
4
Officers
Mr. George Edward Carleton
Executive Vice President of Resource America
Mr. George E. Carlton
Head of CMBS Investing
Mr. Steven Landgraber
Senior Vice President of Corporate Finance & Investor Relations Officer
Mr. Jeffrey Dean Blomstrom
Senior Vice President
Mr. Kyle K. Brengel
Vice President of Operations
Mr. Mark Steven Fogel
President, Chief Executive Officer & Director
Ms. Jaclyn Alyce Jesberger
Chief Legal Officer, Senior Vice President & Secretary
Mr. Eldron C. Blackwell
Senior Vice President, Chief Financial Officer & Treasurer
Ms. Linda M. Kilpatrick
Vice President, Chief Accounting Officer & Controller
Mr. Paul Andrew Hughson J.D.
Executive Vice President of Commercial Real Estate Lending Business Division